Skip to main content
SpringerLink
Log in

Sleep Apnea in Congestive Heart Failure

  • Published:
Current Heart Failure Reports Aims and scope Submit manuscript

Abstract

Obstructive sleep apnea (OSA) is a form of sleep disordered breathing in which pharyngeal muscle relaxation leads to recurrent nighttime apneas and hypopneas that, through increased afterload, intermittent hypoxia, and excess sympathetic activity, weaken the already failing heart. This review presents the current evidence regarding the complex relationship between OSA and heart failure (HF), including support for OSA as both a cause and consequence of HF. The impact of OSA on other cardiovascular diseases, such as hypertension, ischemic heart disease and arrhythmias, as they relate to HF development or exacerbation, also are reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Lloyd-Jones D, Adams RJ, Brown TM, et al.: Heart disease and stroke statistics: 2010 update: a report from the American Heart Association. Circulation 2010, 121:e46–e215.

    Article  PubMed  Google Scholar 

  2. Somers VK, White DP, Amin R, et al.: Sleep apnea and cardiovascular disease: an American Heart Association/American College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 2008, 118:1080–1111.

    Article  PubMed  Google Scholar 

  3. Shahar E, Whitney CW, Redline S, et al.: Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001, 163:19–25.

    CAS  PubMed  Google Scholar 

  4. Javaheri S, Parker TJ, Liming JD, et al.: Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 1998, 97:2154–2159.

    CAS  PubMed  Google Scholar 

  5. • Yumino D, Redolfi S, Ruttanaumpawan P, et al.: Nocturnal rostral fluid shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation 2010, 121:1598–1605. This is a study of 57 patients with HF and both OSA and CSA who had neck circumference and leg fluid volume measured before and after overnight polysomnography. Patients with OSA were offered CPAP. The degree of leg fluid volume reduction correlated with severity of AHI, speaking to pathophysiology of OSA in HF patients.

    Article  PubMed  Google Scholar 

  6. Javaheri S: Sleep disorders in systolic heart failure: a prospective study of 100 male patients. The final report. Int J Cardiol 2006, 106:21–28.

    Article  PubMed  Google Scholar 

  7. Sin DD, Fitzgerald F, Parker JD, et al.: Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999, 160:1101–1106.

    CAS  PubMed  Google Scholar 

  8. • Yumino D, Wang H, Floras JS, et al.: Prevalence and physiological predictors of sleep apnea in patients with heart failure and systolic dysfunction. J Card Fail 2009, 15:279–285. This is a larger series of 218 HF patients with EF of 45% or less referred for sleep study. Of these patients, 26% were diagnosed with OSA. Predictors of OSA were age, male sex, and greater BMI. Overall, this paper showed no improvement in OSA prevalence despite better medical HF therapy.

    Article  PubMed  Google Scholar 

  9. Chan J, Sanderson J, Chan W, et al.: Prevalence of sleep-disordered breathing in diastolic heart failure. Chest 1997, 111:1488–1493.

    Article  CAS  PubMed  Google Scholar 

  10. Chami HA, Devereux RB, Gottdiener JS, et al.: Left ventricular morphology and systolic function in sleep-disordered breathing: the Sleep Heart Health Study. Circulation 2008, 117:2599–2607.

    Article  PubMed  Google Scholar 

  11. •• Wang H, Parker JD, Newton GE, et al.: Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 2007, 49:1625–1631. In this prospective trial of patients with HF, those diagnosed with OSA had a greater mortality than those without OSA during a follow-up period of 7 years. This is one of the first major trials illustrating increased mortality in HF patients with OSA.

    Article  PubMed  Google Scholar 

  12. Trinder J, Kleiman J, Carrington M, et al.: Autonomic activity during human sleep as a function of time and sleep stage. J Sleep Res 2001, 10:253–264.

    Article  CAS  PubMed  Google Scholar 

  13. Bradley TD, Hall MJ, Ando S, Floras JS: Hemodynamic effects of simulated obstructive apneas in humans with and without heart failure. Chest 2001, 119:1827–1835.

    Article  CAS  PubMed  Google Scholar 

  14. Narkiewicz K, Montano N, Cogliati C, et al.: Altered cardiovascular variability in obstructive sleep apnea. Circulation 1998, 98:1071–1077.

    CAS  PubMed  Google Scholar 

  15. • Ishida K, Kato M, Kato Y, et al.: Appropriate use of nasal continuous positive airway pressure decreases elevated C-reactive protein in patients with obstructive sleep apnea. Chest 2009, 136:125–129. In this study, 55 patients with moderate OSA and AHI greater than 20 had CRP levels drawn before and after 6 months of CPAP. Patients with good CPAP compliance of greater than 4 h/night had a significant reduction in CRP levels after treatment.

    Article  CAS  PubMed  Google Scholar 

  16. • Christou K, Kostikas K, Pastaka C, et al.: Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome. Sleep Med 2009, 10:87–94. This is a small study of levels of oxidative stress in patients with documented OSA compared to control patients. Patients with more severe OSA had increased levels of free oxygen radicals which were subsequently decreased with one night of CPAP.

    Article  PubMed  Google Scholar 

  17. Kaneko Y, Floras JS, Usui K, et al.: Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003, 348:1233–1241.

    Article  PubMed  Google Scholar 

  18. Mansfield DR, Gollogly NC, Kaye DM, et al.: Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 2004, 169:361–366.

    Article  PubMed  Google Scholar 

  19. • Egea CJ, Aizpuru F, Pinto JA, et al.: Cardiac function after CPAP therapy in patients with chronic heart failure and sleep apnea: a multicenter study. Sleep Med 2008, 9:660–666. This is one of two randomized CPAP trials in patients with HF employing a true sham CPAP arm. Patients receiving therapeutic CPAP experienced improvement in EF after 3 months. There was a suggestion of a greater magnitude of benefit if the patient’s EF at baseline was greater than 30%.

    Article  PubMed  Google Scholar 

  20. Smith LA, Vennelle M, Gardner RS, et al.: Auto-titrating continuous positive airway pressure therapy in patients with chronic heart failure and obstructive sleep apnoea: a randomized placebo-controlled trial. Eur Heart J 2007, 28:1221–1227.

    Article  PubMed  Google Scholar 

  21. Usui K, Bradley TD, Spaak J, et al.: Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. J Am Coll Cardiol 2005, 45:2008–2011.

    Article  PubMed  Google Scholar 

  22. • Yoshinaga K, Burwash IG, Leech JA, et al.: The effects of continuous positive airway pressure on myocardial energetics in patients with heart failure and obstructive sleep apnea. J Am Coll Cardiol 2007, 49:450–458. Only 12 patients studied in this trial showing decreased oxidative metabolism and improved cardiac efficiency with 6 weeks of CPAP in HF patients with OSA.

    Article  PubMed  Google Scholar 

  23. Ruttanaumpawan P, Gilman MP, Usui K, et al.: Sustained effect of continuous positive airway pressure on baroreflex sensitivity in congestive heart failure patients with obstructive sleep apnea. J Hypertens 2008, 26:1163–1168.

    Article  CAS  PubMed  Google Scholar 

  24. Tkacova R, Rankin F, Fitzgerald FS, et al.: Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation 1998, 98:2269–2275.

    CAS  PubMed  Google Scholar 

  25. •• Kasai T, Narui K, Dohi T, et al.: Prognosis of patients with heart failure and obstructive sleep apnea treated with continuous positive airway pressure. Chest 2008, 133:690–696. This was the first trial to demonstrate that patients with HF and OSA who were compliant with CPAP had a significantly reduced mortality and rehospitalization rate compared to patients who used CPAP but were less compliant.

    Article  PubMed  Google Scholar 

  26. Peppard PE, Young T, Palta M, Skatrud J: Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000, 342:1378–1384.

    Article  CAS  PubMed  Google Scholar 

  27. Gonçalves SC, Martinez D, Gus M, et al.: Obstructive sleep apnea and resistant hypertension: a case-control study. Chest 2007, 132:1858–1862.

    Article  PubMed  Google Scholar 

  28. • Hla KM, Young T, Finn L, et al.: Longitudinal association of sleep-disordered breathing and nondipping of nocturnal blood pressure in the Wisconsin Sleep Cohort Study. Sleep 2008, 31:795–800. In this assessment of over 300 patients in the Sleep Heart Health Study, there was a dose-response increased odds of developing nondipping of systolic blood pressure as the severity of OSA increased, suggesting a causal link between the two conditions.

    PubMed  Google Scholar 

  29. • Campos-Rodriguez F, Perez-Ronchel J, Grilo-Reina A, et al.: Long-term effect of continuous positive airway pressure on BP in patients with hypertension and sleep apnea. Chest 2007, 132:1847–1852. A small study of 55 patients, this trial showed that long-term use of CPAP in patients with OSA modestly reduces blood pressure. Higher starting blood pressure and more hours of CPAP were predictive of blood pressure response.

    Article  PubMed  Google Scholar 

  30. Dernaika TA, Kinasewitz GT, Tawk MM: Effects of nocturnal continuous positive airway pressure therapy in patients with resistant hypertension and obstructive sleep apnea. J Clin Sleep Med 2009, 5:103–107.

    PubMed  Google Scholar 

  31. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al.: Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002, 359:204–210.

    Article  PubMed  Google Scholar 

  32. Chobanian AV, Bakris GL, Black HR, et al.: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289:2560–2572. (Published erratum appears in JAMA 2003, 290:197.)

    Article  CAS  PubMed  Google Scholar 

  33. Schäfer H, Koehler U, Ewig S, et al.: Obstructive sleep apnea as a risk marker in coronary artery disease. Cardiology 1999, 92:79–84.

    Article  PubMed  Google Scholar 

  34. Mooe T, Franklin KA, Holmström K, et al.: Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med 2001, 164:1910–1913.

    CAS  PubMed  Google Scholar 

  35. Peled N, Abinader EG, Pillar G, et al.: Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: effects of continuous positive air pressure treatment. J Am Coll Cardiol 1999, 34:1744–1749.

    Article  CAS  PubMed  Google Scholar 

  36. •• Kuniyoshi FH, Garcia-Touchard A, Gami AS, et al.: Day-night variation of acute myocardial infarction in obstructive sleep apnea. J Am Coll Cardiol 2008, 52:343–346. This was one of the first studies to show the diurnal variation of MI onset in patients with OSA. Patients who have onset of MI between the hours of midnight and 6 AM had high likelihood of having OSA.

    Article  PubMed  Google Scholar 

  37. Geiser T, Buck F, Meyer BJ, et al.: In vivo platelet activation is increased during sleep in patients with obstructive sleep apnea syndrome. Respiration 2002, 69:229–234.

    Article  PubMed  Google Scholar 

  38. Milleron O, Pillière R, Foucher A, et al.: Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J 2004, 25:728–734.

    Article  PubMed  Google Scholar 

  39. Doherty LS, Kiely JL, Swan V, et al.: Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 2005, 127:2076–2084.

    Article  PubMed  Google Scholar 

  40. • Sorajja D, Gami AS, Somers VK, et al.: Independent association between obstructive sleep apnea and subclinical coronary artery disease. Chest 2008, 133:927–933. Patients with subclinical CAD as assessed with coronary calcification score were referred for sleep studies. The presence and extent of coronary calcium score was associated with the severity of OSA.

    Article  PubMed  Google Scholar 

  41. • Yumino D, Wang H, Floras JS, et al.: Relationship between sleep apnoea and mortality in patients with ischaemic heart failure. Heart 2009, 95:819–824. Patients with heart failure referred to the cardiology clinic were sent for sleep studies and followed prospectively. In patients with ICM, the presence of OSA was independently associated with increased risk of mortality.

    Article  CAS  PubMed  Google Scholar 

  42. Mehra R, Benjamin EJ, Shahar E, et al.: Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med 2006, 173:910–916.

    Article  PubMed  Google Scholar 

  43. Gami AS, Pressman G, Caples SM, et al.: Association of atrial fibrillation and obstructive sleep apnea. Circulation 2004, 110:364–367.

    Article  PubMed  Google Scholar 

  44. Gami AS, Hodge DO, Herges RM, et al.: Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 2007, 49:565–571.

    Article  PubMed  Google Scholar 

  45. •• Monahan K, Storfer-Isser A, Mehra R, et al.: Triggering of nocturnal arrhythmias by sleep-disordered breathing events. J Am Coll Cardiol 2009, 54:1797–1804. Patients’ recordings from sleep studies in the Sleep Heart Health Study were examined for arrhythmias, which then were reviewed for temporal respiratory disturbances and desaturations. The relative risk of AF and NSVT is increased in a short period after a respiratory disturbance, which supported a temporal link between SDB and arrhythmia development.

    Article  PubMed  Google Scholar 

  46. Kanagala R, Murali NS, Friedman PA, et al.: Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003, 107:2589–2594.

    PubMed  Google Scholar 

  47. Grimm W, Hoffmann J, Menz V, et al.: Electrophysiologic evaluation of sinus node function and atrioventricular conduction in patients with prolonged ventricular asystole during obstructive sleep apnea. Am J Cardiol 1996, 77:1310–1314.

    Article  CAS  PubMed  Google Scholar 

  48. Garrigue S, Pépin JL, Defaye P, et al.: High prevalence of sleep apnea syndrome in patients with long-term pacing: the European Multicenter Polysomnographic Study. Circulation 2007, 115:1703–1709.

    Article  PubMed  Google Scholar 

  49. Ryan CM, Usui K, Floras JS, Bradley TD: Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. Thorax 2005, 60:781–785.

    Article  CAS  PubMed  Google Scholar 

  50. Gami AS, Howard DE, Olson EJ, Somers VK: Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005, 352:1206–1214.

    Article  CAS  PubMed  Google Scholar 

  51. • Serizawa N, Yumino D, Kajimoto K, et al.: Impact of sleep-disordered breathing on life-threatening ventricular arrhythmia in heart failure patients with implantable cardioverter-defibrillator. Am J Cardiol 2008,102:1064–1068. Patients with ICDs were followed for 180 days after a sleep study for arrhythmias. In patients with OSA and AHI greater than or equal to 10, there was an increased frequency of appropriate ICD treatments. The presence of OSA was an independent predictor of appropriate ICD therapy in the multivariate analysis.

    Article  PubMed  Google Scholar 

  52. Koshino Y, Satoh M, Katayose Y, et al.: Sleep apnea and ventricular arrhythmias: Clinical outcome, electrophysiologic characteristics, and follow-up after catheter ablation. J Cardiol 2010, 55:211–216.

    Article  PubMed  Google Scholar 

  53. Chaouat A, Weitzenblum E, Krieger J, et al.: Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Results in 220 consecutive patients. Chest 1996, 109:380–386.

    Article  CAS  PubMed  Google Scholar 

  54. • Minai OA, Ricaurte B, Kaw R, et al.: Frequency and impact of pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am J Cardiol 2009, 104:1300–1306. Patients who were referred for right heart catheterization within 6 months of a sleep study diagnosing OSA were included in this study. Patients diagnosed with more severe pulmonary hypertension had more nocturnal desaturation events. This study illustrated that PH can occur in patients with OSA and is associated with increased mortality.

    Article  PubMed  Google Scholar 

  55. Sajkov D, Wang T, Saunders NA, et al.: Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2002, 165:152–158.

    PubMed  Google Scholar 

  56. Arias MA, García-Río F, Alonso-Fernández A, et al.: Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study. Eur Heart J 2006, 27:1106–1113.

    Article  PubMed  Google Scholar 

Download references

Disclosures

Dr. Meredith Brisco: none. Dr. Lee Goldberg has received a grant from ResMed Corp.

Author information

Authors and Affiliations

  1. Cardiovascular Medicine, Heart Failure and Cardiac Transplant Program, University of Pennsylvania, 2 East Perelman Center for Advanced Medicine, 3400 Civic Center Boulevard, Philadelphia, PA, 19104, USA

    Meredith A. Brisco & Lee R. Goldberg

Authors
  1. Meredith A. Brisco
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lee R. Goldberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lee R. Goldberg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brisco, M.A., Goldberg, L.R. Sleep Apnea in Congestive Heart Failure. Curr Heart Fail Rep 7, 175–184 (2010). https://doi.org/10.1007/s11897-010-0033-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11897-010-0033-5

Keywords

Search

Navigation